Cognex CorpCGNX
Price$62.22Intrinsic value$52.9815% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.1B+19.1% YoYTTM through 5 Jul 2026
Net Income $174.8M+64.6% YoYTTM through 5 Jul 2026
Free Cash Flow $268.3MTTM through 5 Jul 2026

Margins

Current
Gross Margin71.1%
EBITDA Margin23.0%
Operating Margin22.3%
Net Margin16.1%

Returns

10.7%ROE
8.0%ROA
13.2%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.64x
Net Debt-$296.8Mnet cash position
Cash & Equivalents$302.5M

Quality Metrics

Altman Z-Score12.31
Piotroski F-Score8 / 9
FCF Margin24.6%
Rule of 4029.8
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $994.4M
Diluted EPS$1.04TTM
'19'20'21'22'23'24'25
FY2025: $0.68

Dividend

$0.26Per share, FY20260.43%Yield-34.9%5-yr growth

Capital Allocation

R&D Spend$140.6M
Capex Intensity0.8%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.